Cancer Family
Respiratory System Neoplasm
CI-CAN-00000049Explore in graph →
Non-malignant2,725 active trials51 approved drugs619 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000049Explore in graph →
Clinical trials
11,608 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00806819 | Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC | completed | Phase 3 | 718 | Boehringer IngelheimINDUSTRY | 32 | Feb 2, 2017 | clinicaltrials |
| NCT00349102 | Prevention of Radiation Pneumonitis After Three-dimensional Conformal Radiation Therapy (3D-CRT) in Patients With Non-small-cell Lung Cancer | completed | Phase 3 | 242 | Centre Leon BerardOTHER | 1 | Feb 1, 2017 | clinicaltrials |
| NCT01404260 | Intercalating and Maintenance Use of Iressa Versus Chemotherapy in Selected Advanced Non Small Cell Lung Cancer(ISCAN) | completed | Phase 3 | 219 | Guangdong Association of Clinical TrialsOTHER | 1 | Jan 27, 2017 | clinicaltrials |
| NCT01351116 | A Trial to Evaluate the Improvement in Lung Cancer Patients Receiving Radiation With or Without Brachytherapy(BRACHY) | completed | Phase 3 | 134 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Jan 24, 2017 | clinicaltrials |
| NCT02988635 | Early Palliative Care on Quality of Life of Advanced Cancer Patients | completed | Phase 3 | 281 | Azienda Ospedaliero-Universitaria di ParmaOTHER | 0 | Dec 9, 2016 | clinicaltrials |
| NCT00040885 | Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05) | completed | Phase 3 | 67 | Alliance for Clinical Trials in OncologyOTHER | 1 | Dec 7, 2016 | clinicaltrials |
| NCT01631565 | Early Incorporation of Patient and Family to Attention and Care Program in Oncology Versus Standard of Care(PACO) | completed | Phase 3 | 201 | Instituto Nacional de Cancerologia de MexicoOTHER | 1 | Nov 25, 2016 | clinicaltrials |
| NCT00806923 | A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 1,044 | Hoffmann-La RocheINDUSTRY | 20 | Nov 2, 2016 | clinicaltrials |
| NCT01814553 | ADAM-Afatinib Diarrhea Assessment and Management | completed | Phase 3 | 40 | Boehringer IngelheimINDUSTRY | 1 | Oct 31, 2016 | clinicaltrials |
| NCT02267096 | Lombardi Comprehensive Cancer Center/Legacy Pilot Study to Reduce Adverse Smoking Outcomes in the Context of Lung Cancer Screening | completed | Phase 3 | 95 | Georgetown UniversityOTHER | 1 | Oct 19, 2016 | clinicaltrials |
| NCT00683514 | Oral Chemotherapy And Platinum With Radiotherapy Followed Or Not By Consolidation With The Same Chemotherapy In Locally Advanced Non Small Cell Lung Cancer | completed | Phase 3 | 201 | Pierre Fabre MedicamentINDUSTRY | 1 | Oct 4, 2016 | clinicaltrials |
| NCT00312377 | ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer(ZODIAC) | completed | Phase 3 | 1,690 | Genzyme, a Sanofi CompanyINDUSTRY | 25 | Sep 30, 2016 | clinicaltrials |
| NCT00404924 | ZD6474 (ZACTIMA™) Phase III Study in EGFR Failures | completed | Phase 3 | 1,140 | Genzyme, a Sanofi CompanyINDUSTRY | 22 | Sep 30, 2016 | clinicaltrials |
| NCT00132613 | Trial of Drainage With or Without Bleomycin Instillation for Malignant Pericardial Effusion | completed | Phase 3 | 80 | Japan Clinical Oncology GroupOTHER | 1 | Sep 22, 2016 | clinicaltrials |
| NCT00144989 | A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC | completed | Phase 3 | 281 | Haruhiko FukudaOTHER | 1 | Sep 22, 2016 | clinicaltrials |
| NCT00035152 | Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer | completed | Phase 3 | 444 | Bristol-Myers SquibbINDUSTRY | 1 | Sep 19, 2016 | clinicaltrials |
| NCT00475098 | Effect of Low Molecular Weight Heparin: Tinzaparin in Lung Tumours (TILT)(TILT) | completed | Phase 3 | 553 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Sep 2, 2016 | clinicaltrials |
| NCT00357734 | Iressa Follow-up Trial | completed | Phase 3 | 14 | AstraZenecaINDUSTRY | 1 | Aug 30, 2016 | clinicaltrials |
| NCT01887795 | Phase Ⅲ Trial of WBRT Versus Erlotinib Concurrent Whole-brain Radiation Therapy as first-line Treatment for Patients With Multiple Brain Metastases From Non-small-cell Lung Cancer(ENTER): a Multicentre, Open-label, Randomised Study | completed | Phase 3 | 224 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityOTHER | 1 | Aug 25, 2016 | clinicaltrials |
| NCT00826683 | Detection of Circulating Endothelial Progenitors Cells (EPCs) in Non-small Cell Lung Cancer (NSCLC)(CBNPC:PCE) | completed | Phase 3 | 140 | University Hospital, LimogesOTHER | 1 | Aug 22, 2016 | clinicaltrials |
| NCT00656136 | BIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1) | completed | Phase 3 | 585 | Boehringer IngelheimINDUSTRY | 15 | Jul 26, 2016 | clinicaltrials |
| NCT00003299 | Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer | completed | Phase 3 | 587 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 20, 2016 | clinicaltrials |
| NCT00003387 | Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery | completed | Phase 3 | 366 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 20, 2016 | clinicaltrials |
| NCT00003831 | Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer | completed | Phase 3 | 1,023 | Alliance for Clinical Trials in OncologyOTHER | 3 | Jul 14, 2016 | clinicaltrials |
| NCT00003317 | Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Stage IIIA Non-small Cell Lung Cancer | completed | Phase 3 | 480 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 13, 2016 | clinicaltrials |
| NCT00003600 | Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy | completed | Phase 3 | 344 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 13, 2016 | clinicaltrials |
| NCT00003674 | Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer | completed | Phase 3 | 141 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 13, 2016 | clinicaltrials |
| NCT00006349 | Donepezil and Vitamin E to Prevent Side Effects Caused By Radiation Therapy to the Head in Patients Receiving Treatment for Small Cell Lung Cancer | completed | Phase 3 | 9 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 13, 2016 | clinicaltrials |
| NCT00033592 | Comparison of Nicotine Inhaler and/or Bupropion in Helping People to Stop Smoking and Prevent the Recurrence of Smoking | completed | Phase 3 | 1,708 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 13, 2016 | clinicaltrials |
| NCT00003117 | Paclitaxel With or Without Carboplatin in Treating Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 3 | 584 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jun 30, 2016 | clinicaltrials |
| NCT00686959 | Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer(PROCLAIM) | completed | Phase 3 | 598 | Eli Lilly and CompanyINDUSTRY | 19 | Jun 28, 2016 | clinicaltrials |
| NCT01441752 | Efficacy Study of Integrated TCM Combined With Chemotherapy in Postoperative NSCLC Patients | completed | Phase 3 | 349 | xulingOTHER | 1 | Jun 27, 2016 | clinicaltrials |
| NCT00259064 | Iressa v BSC (Best Supportive Care) in First Line NSCLC(INSTEP) | completed | Phase 2 / Phase 3 | 216 | AstraZenecaINDUSTRY | 5 | Jun 2, 2016 | clinicaltrials |
| NCT00257608 | A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS) | completed | Phase 3 | 1,145 | Genentech, Inc.INDUSTRY | 17 | Apr 18, 2016 | clinicaltrials |
| NCT01082549 | Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC)(ECLIPSE) | completed | Phase 3 | 780 | SanofiINDUSTRY | 14 | Mar 17, 2016 | clinicaltrials |
| NCT00216125 | Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer | completed | Phase 3 | 243 | Nasser Hanna, M.D.OTHER | 1 | Mar 16, 2016 | clinicaltrials |
| NCT00198354 | Stage I/II NSCLC Perioperative Chemotherapy | completed | Phase 3 | 530 | Intergroupe Francophone de Cancerologie ThoraciqueOTHER | 1 | Mar 10, 2016 | clinicaltrials |
| NCT00930891 | Bevacizumab in Extensive Small Cell Lung Cancer(CPC) | completed | Phase 2 / Phase 3 | 143 | Intergroupe Francophone de Cancerologie ThoraciqueOTHER | 1 | Mar 10, 2016 | clinicaltrials |
| NCT00976456 | Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer(65plus) | completed | Phase 3 | 271 | PD Dr. med. Wolfgang SchuetteOTHER | 1 | Mar 10, 2016 | clinicaltrials |
| NCT01355484 | Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 321 | GTxINDUSTRY | 1 | Mar 3, 2016 | clinicaltrials |
| NCT00123760 | Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer | completed | Phase 2 / Phase 3 | 10,838 | AHS Cancer Control AlbertaOTHER | 1 | Feb 25, 2016 | clinicaltrials |
| NCT01769066 | Clinical Value of Sequential Gefitinib With Pemetrexed/Platinum for Advanced NSCLC | completed | Phase 2 / Phase 3 | 117 | Fudan UniversityOTHER | 1 | Feb 23, 2016 | clinicaltrials |
| NCT00961415 | AVAPERL1 Study: A Study of Avastin (Bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small Cell Lung Cancer | completed | Phase 3 | 376 | Hoffmann-La RocheINDUSTRY | 12 | Feb 22, 2016 | clinicaltrials |
| NCT01310387 | Prospective Study of Active Pain Management in Lung Cancer Outpatients (APM)(APM) | completed | Phase 3 | 79 | Chonnam National University HospitalOTHER | 1 | Feb 5, 2016 | clinicaltrials |
| NCT01326767 | Central European Society for Anticancer Research (CESAR) Study of Paclitaxel Therapeutic Drug Monitoring(CEPAC-TDM) | completed | Phase 3 | 366 | Central European Society for Anticancer Drug ResearchOTHER | 2 | Jan 27, 2016 | clinicaltrials |
| NCT00349219 | TORCH: A Study of Tarceva or Chemotherapy for the Treatment of Advanced Non Small Cell Lung Cancer(TORCH) | completed | Phase 3 | 760 | National Cancer Institute, NaplesOTHER | 2 | Jan 15, 2016 | clinicaltrials |
Data updated 22 days agoSource updated Feb 2, 2017source: clinicaltrials